Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Integrase Inhibitors | 1 | 2023 | 142 | 0.800 |
Why?
|
HIV Protease Inhibitors | 1 | 2024 | 430 | 0.790 |
Why?
|
Viral Vaccines | 1 | 2022 | 636 | 0.580 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4561 | 0.510 |
Why?
|
Anti-HIV Agents | 2 | 2024 | 4255 | 0.370 |
Why?
|
HIV Infections | 4 | 2024 | 16715 | 0.360 |
Why?
|
Antibodies, Neutralizing | 6 | 2023 | 1978 | 0.320 |
Why?
|
Immune Evasion | 2 | 2021 | 360 | 0.310 |
Why?
|
Drug Resistance, Viral | 2 | 2023 | 820 | 0.280 |
Why?
|
Antibodies, Viral | 5 | 2023 | 3175 | 0.270 |
Why?
|
Ghana | 2 | 2022 | 284 | 0.250 |
Why?
|
Ritonavir | 2 | 2024 | 322 | 0.240 |
Why?
|
Schistosomiasis | 1 | 2023 | 62 | 0.230 |
Why?
|
Oxazines | 1 | 2023 | 298 | 0.200 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2023 | 215 | 0.200 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 403 | 0.190 |
Why?
|
Integrases | 1 | 2023 | 533 | 0.190 |
Why?
|
Peptide Hydrolases | 1 | 2024 | 633 | 0.190 |
Why?
|
Membrane Fusion | 1 | 2022 | 276 | 0.180 |
Why?
|
Serine Endopeptidases | 2 | 2022 | 1073 | 0.170 |
Why?
|
RNA | 3 | 2024 | 2748 | 0.170 |
Why?
|
Pyridones | 1 | 2023 | 711 | 0.160 |
Why?
|
Mutation | 5 | 2024 | 29777 | 0.160 |
Why?
|
Vaccination | 4 | 2023 | 3275 | 0.160 |
Why?
|
Drug Resistance | 1 | 2024 | 1606 | 0.150 |
Why?
|
Virus Internalization | 1 | 2022 | 501 | 0.150 |
Why?
|
Antibody Formation | 1 | 2022 | 1402 | 0.150 |
Why?
|
HIV Seropositivity | 1 | 2023 | 971 | 0.150 |
Why?
|
Viral Load | 2 | 2024 | 3300 | 0.150 |
Why?
|
Hepatitis B | 1 | 2022 | 693 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1836 | 0.140 |
Why?
|
Virus Replication | 2 | 2022 | 2535 | 0.140 |
Why?
|
Fatty Liver | 1 | 2022 | 728 | 0.140 |
Why?
|
Immunity | 1 | 2021 | 1013 | 0.130 |
Why?
|
HIV-1 | 2 | 2023 | 6939 | 0.120 |
Why?
|
DNA, Viral | 1 | 2019 | 2226 | 0.110 |
Why?
|
DNA | 1 | 2024 | 7295 | 0.090 |
Why?
|
India | 2 | 2021 | 2200 | 0.060 |
Why?
|
Humans | 12 | 2024 | 743811 | 0.060 |
Why?
|
Genitalia | 1 | 2023 | 112 | 0.050 |
Why?
|
Stavudine | 1 | 2022 | 85 | 0.050 |
Why?
|
Malawi | 1 | 2023 | 282 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25032 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8655 | 0.050 |
Why?
|
Convalescence | 1 | 2022 | 105 | 0.050 |
Why?
|
Immune Sera | 1 | 2022 | 641 | 0.050 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 97 | 0.050 |
Why?
|
Cell Fusion | 1 | 2021 | 297 | 0.050 |
Why?
|
Tissue Culture Techniques | 1 | 2022 | 291 | 0.050 |
Why?
|
Vero Cells | 1 | 2021 | 485 | 0.050 |
Why?
|
Cameroon | 1 | 2019 | 71 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 291 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2021 | 340 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2022 | 513 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2022 | 372 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2021 | 634 | 0.040 |
Why?
|
Adult | 5 | 2023 | 213889 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1328 | 0.040 |
Why?
|
Health Personnel | 2 | 2021 | 3217 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 995 | 0.040 |
Why?
|
Cell Line | 2 | 2022 | 15993 | 0.040 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2019 | 615 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1604 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1347 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2021 | 1904 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6476 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2037 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3205 | 0.030 |
Why?
|
Intestines | 1 | 2022 | 1923 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1859 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4204 | 0.030 |
Why?
|
Cell Membrane | 1 | 2022 | 3749 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1872 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8316 | 0.020 |
Why?
|
Male | 6 | 2023 | 349776 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6487 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9377 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4665 | 0.020 |
Why?
|
Middle Aged | 4 | 2022 | 213241 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2022 | 57744 | 0.020 |
Why?
|
Female | 5 | 2022 | 380020 | 0.020 |
Why?
|
Aged | 3 | 2023 | 163178 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10179 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9858 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10629 | 0.010 |
Why?
|
Animals | 2 | 2022 | 168660 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53250 | 0.010 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_